Form 4: Abeona Therapeutics Director Mark Alvino Sells 4,000 Shares

Director Mark Alvino sold 4,000 shares of Abeona Therapeutics Inc. common stock at an average price of $5.10 on January 21, 2025.

Summary

• On January 21, 2025, Mark Alvino, a director of Abeona Therapeutics Inc., sold 4,000 shares of common stock.
• The shares were sold at a weighted average price of $5.10, with individual transaction prices ranging from $5.08 to $5.12.
• Following the transaction, Alvino directly owns 68,334 shares of Abeona Therapeutics Inc.

Sentiment

Score: 5

Explanation: This is a neutral disclosure of a stock sale by a company director. It doesn't inherently indicate positive or negative sentiment, but rather provides factual information about the transaction.

Industry Context

This Form 4 filing is a routine disclosure of insider trading activity. It provides transparency into the transactions of company insiders, allowing investors to monitor potential shifts in sentiment or alignment of interests.

Stakeholder Impact

• The sale of shares by a director could be perceived neutrally or slightly negatively by shareholders, depending on the context and the size of the transaction relative to the director's total holdings.

Key Dates